KyungSunParkMD

PubMed

• SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.
  Shoag, J.,Liu, D.,Blattner, M.,Sboner, A.,Park, K.,Deonarine, L.,Robinson, B. D.,Mosquera, J. M.,Chen, Y.,Rubin, M. A.,Barbieri, C. E.> ;J. Clin. Invest.. 2017 Dec 05
• Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
  Park, K.,Chen, Z.,MacDonald, T. Y.,Siddiqui, J.,Ye, H.,Erbersdobler, A.,Shevchuk, M. M.,Robinson, B. D.,Sanda, M. G.,Chinnaiyan, A. M.,Beltran, H.,Rubin, M. A.,Mosquer...> ;Hum. Pathol.. 2014 Aug 17
• 121 citations
  Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
  Francesca Khani, Juan Miguel Mosquera, Kyung Park, Mirjam Blattner, Catherine O'Reilly, Theresa Y. MacDonald, Zhengming Chen, Abhishek Kumar Srivastava, Ashutosh K. Te...> ;Clinical Cancer Research. 2014 Jul 23
• SPOP Mutations in Prostate Cancer across Demographically Diverse Patient Cohorts.
  Blattner, M.,Lee, D. J.,O'Reilly, C.,Park, K.,Macdonald, T. Y.,Khani, F.,Turner, K. R.,Chiu, Y. L.,Wild, P. J.,Dolgalev, I.,Heguy, A.,Sboner, A.,Ramazangolu, S.,Hieron...> ;Neoplasia. 2014 Feb 25
• TMPRSS2:ERG Gene Fusion Predicts Subsequent Detection of Prostate Cancer in Patients With High-Grade Prostatic Intraepithelial Neoplasia.
  Park, K.,Dalton, J. T.,Narayanan, R.,Barbieri, C. E.,Hancock, M. L.,Bostwick, D. G.,Steiner, M. S.,Rubin, M. A.> ;J. Clin. Oncol.. 2013 Dec 04
• V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in pros...
  Park, K.,Chiu, Y. L.,Rubin, M. A.,Demichelis, F.,Mosquera, J. M.> ;Hum. Pathol.. 2013 Oct
• Punctuated evolution of prostate cancer genomes.
  Baca, S. C.,Prandi, D.,Lawrence, M. S.,Mosquera, J. M.,Romanel, A.,Drier, Y.,Park, K.,Kitabayashi, N.,Macdonald, T. Y.,Ghandi, M.,Van Allen, E.,Kryukov, G. V.,Sboner, ...> ;Cell. 2013 Apr 25
• Epigenomic alterations in localized and advanced prostate cancer.
  Lin, P. C.,Giannopoulou, E. G.,Park, K.,Mosquera, J. M.,Sboner, A.,Tewari, A. K.,Garraway, L. A.,Beltran, H.,Rubin, M. A.,Elemento, O.> ;Neoplasia. 2013 Apr
• Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression.
  Lin, P. C.,Chiu, Y. L.,Banerjee, S.,Park, K.,Mosquera, J. M.,Giannopoulou, E.,Alves, P.,Tewari, A. K.,Gerstein, M. B.,Beltran, H.,Melnick, A. M.,Elemento, O.,Demicheli...> ;Cancer Res. 2013 Feb 1
• Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal Treatment-Related Neuroendocrine Prostate Cancer.
  Mosquera, J. M.,Beltran, H.,Park, K.,Macdonald, T. Y.,Robinson, B. D.,Tagawa, S. T.,Perner, S.,Bismar, T. A.,Erbersdobler, A.,Dhir, R.,Nelson, J. B.,Nanus, D. M.,Rubin...> ;Neoplasia. 2013 Jan
• Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.
  Bhalla, R.,Kunju, L. P.,Tomlins, S. A.,Christopherson, K.,Cortez, C.,Carskadon, S.,Siddiqui, J.,Park, K.,Miguel Mosquera, J.,Pestano, G. A.,Rubin, M. A.,Chinnaiyan, A....> ;Mod Pathol. 2013 Jun
• Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer.
  Beltran, H., Tagawa, S. T., Park, K., Macdonald, T., Milowsky, M. I., Mosquera, J. M., Rubin, M. A., Nanus, D. M.> ;J Clin Oncol. 2012 Dec 20
• Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity.
  Beltran, H., Yelensky, R., Frampton, G. M., Park, K., Downing, S. R., Macdonald, T. Y., Jarosz, M., Lipson, D., Tagawa, S. T., Nanus, D. M., Stephens, P. J., Mosquera,...> ;Eur Urol. 2013 May
• Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy.
  Rink, M., Park, K., Volkmer, B. G., Xylinas, E., Hansen, J., Cha, E. K., Robinson, B. D., Hautmann, R., Küfer, R., Engel, O., Chun, F. K., Dahlem, R., Rubin, M. A., Sh...> ;Urol Oncol. 2012 Sep 1
• 22 citations
  Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome Consortium.
  Raquel Esgueva, Kyung Park, Robert Kim, Naoki Kitabayashi, Christopher E. Barbieri, Philip Dorsey, Cyril Abraham, Samprit Banerjee, Robert Leung, Ashutosh Tewari, Stép...> ;Diagnostic Molecular Pathology. 2012 Jun 1
• Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
  Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J. P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., Nickerson, E.,...> ;Nat Genet. 2012 Jun
• 263 citations
  Antibody-based detection of ERG rearrangement-positive prostate cancer.
  Kyung Park, Scott A. Tomlins, Kumaran Mudaliar, Ya Lin Chiu, Raquel Esgueva, Rohit Mehra, Khalid Suleman, Sooryanarayana Varambally, J.C. Brenner, Theresa Y. MacDonald...> ;Neoplasia. 2010 Jul 1
• The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
  Chakravarty, D.,Sboner, A.,Nair, S. S.,Giannopoulou, E.,Li, R.,Hennig, S.,Mosquera, J. M.,Pauwels, J.,Park, K.,Kossai, M.,MacDonald, T. Y.,Fontugne, J.,Erho, N.,Vergar...> ;Nat Commun. 2014 Nov 22
• Join now to see all